Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer

Molecular Biology Reports

Volumn 41, Issue 1, 2014, Pages 459-466

  Eftekhar, Ebrahim ^a   Naghibalhossaini, Fakhraddin ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5 Fluorouracil; CEA; Chemotherapy; Colorectal cancer; Drug resistance

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; FLUOROURACIL; METHOTREXATE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHO CELL; COLORECTAL CANCER; DRUG SENSITIVITY; HUMAN; IC 50; MONOLAYER CULTURE; NONHUMAN; PREDICTION; TREATMENT RESPONSE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; CHO CELLS; CISPLATIN; COLORECTAL NEOPLASMS; CRICETINAE; CRICETULUS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FLUOROURACIL; GENE EXPRESSION; HUMANS; INHIBITORY CONCENTRATION 50; METHOTREXATE; SPHEROIDS, CELLULAR;

EID: 84891943954     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2880-0     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
2. Malet-Martino M, Jolimaitre P, Martino R (2002) The prodrugs of 5-fluorouracil. Curr Med Chem Anticancer Agents 2(2):267-310
3. Isacoff WH, Borud K (1997) Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overview. World J Surg 21(7):748-762
4. Furuta T (2009) Pharmacogenomics in chemotherapy for GI tract cancer. J Gastroenterol 44(10):1016-1025
5. Peters GJ, Backus HH, Freemantle S, van Triest B, Codacci-Pisanelli G, van der Wilt CL, Smid K, Lunec J, Calvert AH, Marsh S, McLeod HL, Bloemena E, Meijer S, Jansen G, van Groeningen CJ, Pinedo HM (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta 1587(2-3):194-205
6. Chan CH, Stanners CP (2007) Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6. Curr Oncol 14(2):70-73
7. Goldstein MJ, Mitchell EP (2005) Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23(4):338-351
8. Ilantzis C, DeMarte L, Screaton RA, Stanners CP (2002) Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 4(2):151-163
9. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24(33):5313-5327
10. Park IJ, Kim HC, Yu CS, Yoo JH, Kim JC (2005) Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer. J Korean Med Sci 20(4):624-627
11. Lin JZ, Zeng ZF, Wu XJ, Wan DS, Chen G, Li LR, Lu ZH, Ding PR, Pan ZZ (2010) Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response. J Int Med Res 38(2):645-654
12. Li M, Li JY, Zhao AL, He JS, Zhou LX, Li YA, Gu J (2009) Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer. Colorectal Dis 11(3):276-281
13. Ordonez C, Screaton RA, Ilantzis C, Stanners CP (2000) Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 60(13):3419-3424
14. Chan CH, Camacho-Leal P, Stanners CP (2007) Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family member expression in transgenic mice. PLoS ONE 2(12):e1353
15. Samara RN, Laguinge LM, Jessup JM (2007) Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling. Cancer Res 67(10):4774-4782
16. Soeth E, Wirth T, List HJ, Kumbhani S, Petersen A, Neumaier M, Czubayko F, Juhl H (2001) Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin Cancer Res 7(7):2022-2030
17. Li HL, Wang TS, Li XY, Li N, Huang DZ, Chen Q, Ba Y (2007) Overexpression of cyclin L2 induces apoptosis and cell-cycle arrest in human lung cancer cells. Chin Med J (Engl) 120(10):905-909
18. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA (2009) Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4(3):309-324
19. Naghibalhossaini F, Pakdel A, Ghaderi AA, Saberi Firoozi M (2005) Effective production of carcinoembryonic antigen by conversion of the membrane-bound into a recombinant secretory protein by site-specific mutagenesis. Pathol Oncol Res 11(4):211-217
20. Pakdel A, Naghibalhossaini F, Mokarram P, Jaberipour M, Hosseini A (2012) Regulation of carcinoembryonic antigen release from colorectal cancer cells. Mol Biol Rep 39(4):3695-3704
21. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
22. Han JS, Nair PP (1995) Flow cytometric identification of cell surface markers on cultured human colonic cell lines using monoclonal antibodies. Cancer 76(2):195-200
23. Green SK, Francia G, Isidoro C, Kerbel RS (2004) Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro. Mol Cancer Ther 3(2):149-159
24. St Croix B, Kerbel RS (1997) Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9(6):549-556
25. Smalley KS, Lioni M, Herlyn M (2006) Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Animal 42(8-9):242-247
26. Ballesta AM, Molina R, Filella X, Jo J, Gimenez N (1995) Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol 16(1):32-41
27. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, Micheel B, Brummer J, Laffer U, Metzger U, Herrmann R, Rochlitz C (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 21(19):3638-3646
28. Bandres E, Zarate R, Ramirez N, Abajo A, Bitarte N, Gariia-Foncillas J (2007) Pharmacogenomics in colorectal cancer: the first step for individualized-therapy. World J Gastroenterol 13(44):5888-5901
29. Longley DB, Johnston PG (2005) Molecular mechanisms of drug resistance. J Pathol 205(2):275-292
30. Prete SP, Turriziani M, Massara MC, De Rossi A, Correale P, De Vecchis L, Torino F, Bonmassar L, Aquino A (2008) Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy. J Exp Clin Cancer Res 270:5
31. Aquino A, Prete SP, Guadagni F, Greiner JW, Giuliani A, Orlando L, Masci G, De Santis S, Bonmassar E, Graziani G (2000) Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells. Anticancer Res 20(5B):3475-3484
32. Cappelletti D, Cardillo A, Bonanno E, Prete SP, Cucchiara G, Turriziani M, Greiner JW, Cottarelli A, Breda E, Aquino A, Bonmassar E, De Vecchis L (2000) Drug-induced modulation of carcinoembryonic antigen (CEA) expression in neoplastic cells from a patient with rectal cancer. J Exp Clin Cancer Res 19(4):467-469
33. Sørbye H, Dahl O (2004) Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer. Acta Oncol 43(5):495-834
34. Duffy MJ (2001) Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47(4):624-630
35. Bidart JM, Thuillier F, Augereau C, Chalas J, Daver A, Jacob N, Labrousse F, Voitot H (1999) Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin Chem 45(10):1695-1707
36. Leteurtre E, Gouyer V, Rousseau K, Moreau O, Barbat A, Swallow D, Huet G, Lesuffleur T (2004) Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate. Biol Cell 96(2):145-151
37. Graham CH, Kobayashi H, Stankiewicz KS, Man S, Kapitain SJ, Kerbel RS (1994) Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst 86(13):975-982
38. Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240(4849):177-184
39. Jessup JM, Brown D, Fitzgerald W, Ford RD, Nachman A, Goodwin TJ, Spaulding G (1997) Induction of carcinoembryonic antigen expression in a three-dimensional culture system. In Vitro Cell Dev Biol Animal 33(5):352-357
40. Tung YC, Hsiao AY, Allen SG, Torisawa YS, Ho M, Takayama S (2011) High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 136(3):473-478